bell
The current prices are delayed by 15 mins, login to check live prices.
SMS Pharmaceuticals Ltd share price logo

SMS Pharmaceuticals Ltd

(SMSPHARMA)

₹231.554.67%

as on 04:01PM, 20 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

SMS Pharmaceuticals Ltd Performance

  • Day's Low

    Day's High

    ₹230
    Day's Price Range
    ₹244.5
  • 52 Week's Low

    52 Week's High

    ₹113.3
    52-Week Price Range
    ₹398
1 Month Return+ 1.5 %
3 Month Return-35.54 %
1 Year Return+ 104.89 %
Previous Close₹242.90
Open₹244.50
Volume1.59L
Upper Circuit-
Lower Circuit-
Market Cap₹2,013.45Cr

SMS Pharmaceuticals Ltd Key Statistics

P/E Ratio34.6
PEG Ratio10.3
Market Cap₹2,013.45 Cr
P/B Ratio2.78
EPS5.81
Dividend Yield0
SectorPharmaceuticals
ROE9.28

SMS Pharmaceuticals Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹2,013.45 Cr100.85%0.67₹49 Cr₹709 Cr
NA₹435.76 Cr272.24%0.54₹28 Cr₹601 Cr
NA₹15.41 Cr278.33%0.50NANA
BUY₹23,100.09 Cr3.59%0.52NANA
NA₹706.49 Cr-0.07%0.57₹9 Cr₹179 Cr

About SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Limited is a public company founded in December 1987. Focused on manufacturing Active Pharmaceutical Ingredients and intermediates, the company has two facilities in Hyderabad and one in Vijayanagaram Dist. During 2015, the company successfully completed US FDA audits, filed nine Drug Master Files, and became an associate company of M/s. VKT Pharma Private Limited by acquiring 1,225,900 equity shares. During 2016-17, the company also acquired 511,400 shares in Sireen Drugs Private Limited and invested in SMS Lifesciences India Limited. 2017-18 saw the Scheme of Arrangement between Demerged and Resulting Companies, approved by Hon’ble National Company Law Tribunal and investment of 784,100 equity shares in VKT Pharma PVT LTD. In FY 2018-19, the company had 38,501,65 equity shares in VKT Pharma PVT LTD.

Share Price: ₹231.55 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹2,013.45Cr as of today
Revenue: ₹196.75Cr as on September 2024 (Q3 24)
Net Profit: ₹13.86Cr as on September 2024 (Q3 24)
Listing date: 28 Feb, 2007
Chairperson Name: P Ramesh Babu
OrganisationSMS Pharmaceuticals Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for SMS Pharmaceuticals Ltd

  • SMS Pharma Reports Strong Q3 Growth in 2024 - 10 Dec, 2024

    SMS Pharmaceuticals Ltd reported consolidated net sales of Rs 196.75 crore for September 2024, an 18.07% increase year-on-year. Net profit rose 20.25% to Rs 14.10 crore, while EBITDA increased by 14.46%. The company's EPS improved to Rs 1.67. SMS Pharma shares closed at Rs 257.70, reflecting a 26.95% return over the last six months and 116.46% over the past year.

Insights on SMS Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.17% to 0.52% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SMSPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 2.13% to 2.55% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 165.82 Cr → 198.05 Cr (in ₹), with an average increase of 16.3% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 64.67% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 33.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, SMSPHARMA stock has moved down by -33.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 17.28 Cr → 14.1 Cr (in ₹), with an average decrease of 9.5% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 33.03% to 32.26% in Sep 2024 quarter

SMS Pharmaceuticals Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹166.64Cr (-)₹161.48Cr (↓3.10%)₹245.80Cr (↑52.22%)₹164.45Cr (↓33.10%)₹196.75Cr (↑19.64%)
Net Income₹12.05Cr (-)₹12.29Cr (↑1.99%)₹16.05Cr (↑30.59%)₹16.37Cr (↑1.99%)₹13.86Cr (↓15.33%)
Net Profit Margin7.23% (-)7.61% (↑5.26%)6.53% (↓14.19%)9.95% (↑52.37%)7.04% (↓29.25%)
Value in ₹ crore
Details2021202220232024
Total Assets₹835.28Cr (-)₹886.36Cr (↑6.12%)₹917.06Cr (↑3.46%)₹1,070.81Cr (↑16.77%)
Total Liabilities₹407.05Cr (-)₹392.59Cr (↓3.55%)₹421.96Cr (↑7.48%)₹500.31Cr (↑18.57%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹39.71Cr (-)₹90.45Cr (↑127.78%)₹45.06Cr (↓50.18%)₹22.45Cr (↓50.18%)₹50.12Cr (↑123.25%)

Index Inclusions

BSE Healthcare

₹44,095.46

-1.13 (-505.02%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹55,149.22

-2.11 (-1188.47%)

SMS Pharmaceuticals Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
64.67%
0.00
Foreign Institutions
0.52%
203.98
Mutual Funds
2.55%
19.42
Retail Investors
32.26%
-2.31
Others
0%
0.00

SMS Pharmaceuticals Ltd Key Indicators

Details20202021202220232024
Book Value Per Share (₹)41.1448.555.5654.459.98
Details20202021202220232024
Earning Per Share (₹)3.867.28.020.465.81
Details20202021202220232024
Return On Equity %9.2415.3214.760.839.28
Details20202021202220232024
Return On Assets %4.937.497.02-0.774.65

SMS Pharmaceuticals Ltd Valuation

SMS Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-163.97x)

June 20, 2023

Today (34.60x)

December 19, 2024

Industry (56.23x)

December 19, 2024

Highest (2093.00x)

November 11, 2022

LowHigh

SMS Pharmaceuticals Ltd Earnings and Dividends

  • SMS Pharmaceuticals Ltd Earnings Results

    SMS Pharmaceuticals Ltd’s net profit jumped 20.2% since last year same period to ₹14.10Cr in the Q2 2024-2025. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated -14.44% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • SMS Pharmaceuticals Ltd Dividends May,2024

    In the quarter ending March 2024, SMS Pharmaceuticals Ltd has declared dividend of ₹0.40 - translating a dividend yield of 0.17%.

    Read More about Dividends

SMS Pharmaceuticals Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

SMS Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on SMS Pharmaceuticals Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy SMS Pharmaceuticals Ltd shares.

SMS Pharmaceuticals Ltd (SMSPHARMA) share price today is ₹231.55

SMS Pharmaceuticals Ltd is listed on NSE

SMS Pharmaceuticals Ltd is listed on BSE

  • Today’s highest price of SMS Pharmaceuticals Ltd is ₹244.5.
  • Today’s lowest price of SMS Pharmaceuticals Ltd is ₹230.

PE Ratio of SMS Pharmaceuticals Ltd is 34.6

PE ratio = SMS Pharmaceuticals Ltd Market price per share / SMS Pharmaceuticals Ltd Earnings per share

Today’s traded volume of SMS Pharmaceuticals Ltd(SMSPHARMA) is 1.59L.

Today’s market capitalisation of SMS Pharmaceuticals Ltd(SMSPHARMA) is ₹2013.45Cr.

SMS Pharmaceuticals Ltd(SMSPHARMAPrice
52 Week High
₹398
52 Week Low
₹113.3

SMS Pharmaceuticals Ltd(SMSPHARMA) share price is ₹231.55. It is down -41.82% from its 52 Week High price of ₹398

SMS Pharmaceuticals Ltd(SMSPHARMA) share price is ₹231.55. It is up 104.37% from its 52 Week Low price of ₹113.3

SMS Pharmaceuticals Ltd(SMSPHARMAReturns
1 Day Returns
-11.35%
1 Month Returns
1.5%
3 Month Returns
-35.54%
1 Year Returns
104.89%